Punjab health authorities have warned citizens against using a suspected counterfeit Azomax 250mg batch after laboratory tests found serious concerns over its authenticity and safety.

WEBDESK – UzGul – MEDIABITES NEWS

Authorities Issue Urgent Medicine Warning

Punjab health authorities have issued an urgent advisory asking the public not to use a specific batch of Azomax 250mg (Azithromycin) capsules after laboratory testing identified it as a suspected counterfeit product.

The warning applies to consumers, pharmacies, hospitals and distributors, all of whom have been instructed to stop using or supplying the affected medicine while the investigation continues.

Officials Identify the Affected Batch

According to the official notification, the alert concerns Batch H5332 of Azomax 250mg capsules.

Testing carried out by the Drug Testing Laboratory Punjab concluded that the batch did not originate from the approved manufacturing process, leading authorities to classify it as a spurious medicine under the Drugs Act.

Officials said the identification of the affected batch followed laboratory examination and regulatory checks aimed at preventing unsafe medicines from reaching patients.

Original Manufacturer Rejects the Batch

Health officials said the company responsible for producing genuine Azomax confirmed that the identified capsules were not manufactured through its authorized production facility.

The confirmation has increased concerns that counterfeit medicines may have entered the pharmaceutical supply chain through illegal or unauthorized channels.

Authorities are now working to trace the movement of the suspected batch and determine how it reached pharmacies or medical suppliers.

Medical Stores Asked to Remove the Product

Drug inspectors have instructed pharmacies, hospitals, distributors and wholesalers to immediately separate and stop selling the affected batch.

Healthcare facilities have also been directed to cooperate with regulators by providing stock details and assisting with inspections.

Officials warned that any remaining supply of the suspected medicine should be removed from circulation until further instructions are issued.

Consumers Advised to Purchase Medicines Carefully

Authorities are encouraging the public to purchase medicines only from licensed pharmacies and authorized medical stores.

Anyone who already has Azomax 250mg from the affected batch has been advised not to use it and seek guidance from a qualified pharmacist or healthcare professional.

Consumers are also being encouraged to check medicine packaging, batch numbers and expiry dates before purchasing pharmaceutical products.

Inspection Campaign Expanded Across Punjab

The Directorate of Drugs Control has expanded inspections across Punjab to locate and remove any remaining stock of the suspected counterfeit medicine.

Officials are reviewing supply chains and checking distributors to identify possible sources responsible for circulating the unauthorized product.

Regulatory teams are also collecting information from pharmacies to ensure the affected batch is removed completely.

Counterfeit Medicines Can Endanger Lives

Medical experts warn that fake or spurious medicines can seriously affect patient health.

Such products may contain incorrect ingredients, improper dosages or no active medicine at all, making them ineffective against infections and potentially delaying proper treatment.

Experts say counterfeit antibiotics are particularly concerning because misuse or ineffective treatment can contribute to antibiotic resistance.

Azithromycin Remains a Commonly Used Antibiotic

Azomax contains azithromycin, a widely prescribed antibiotic used for treating bacterial infections involving the throat, lungs, ears, skin and respiratory system.

Because azithromycin is commonly prescribed to adults and children, healthcare professionals stress that strict quality control is necessary to protect patients.

Doctors advise people not to use antibiotics without proper medical guidance.

Patients Urged Not to Stop Treatment Without Advice

Doctors have advised patients currently taking azithromycin not to panic or discontinue treatment without confirming whether their medicine belongs to the affected batch.

Patients who are unsure about their medication should consult their doctor or pharmacist before making any changes.

Healthcare experts emphasize that stopping prescribed antibiotics suddenly can affect treatment outcomes.

Healthcare Workers Asked to Stay Alert

Hospitals, clinics and pharmacists have been asked to remain vigilant and immediately report any suspected counterfeit medicines to relevant authorities.

Officials believe quick reporting can help regulators identify unsafe products faster and prevent further distribution.

Healthcare providers have also been reminded to maintain accurate medicine records during inspections.

Drug Safety Requires Continuous Monitoring

Health regulators say regular laboratory testing and market surveillance are essential to maintaining the quality of medicines available to the public.

The latest alert highlights the need for cooperation between pharmaceutical companies, healthcare providers and government agencies.

Authorities say monitoring systems play an important role in detecting problems before they affect larger numbers of patients.

Public Awareness Can Help Stop Fake Medicines

Officials say consumers can support efforts against counterfeit medicines by purchasing products from trusted sources and reporting suspicious packaging or suppliers.

Checking labels, batch numbers and manufacturer details can help identify possible issues before medicines are consumed.

Greater public awareness is considered a key step in reducing the circulation of unsafe pharmaceutical products.

Investigation Into Supply Chain Continues

Authorities are continuing their investigation into how the suspected counterfeit Azomax batch entered the market and whether additional stocks remain available.

Officials are examining distribution records and may take further action if more unauthorized products are discovered.

The public has been advised to follow official health updates and avoid using the affected batch until the investigation is completed.